Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 646

The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

Open access
Agostoni, Angelo, Aygören-Pürsün, Emel, Binkley, Karen E., Blanch, Alvaro, Bork, Konrad, Bouillet, Laurence, Bucher, Christoph, Castaldo, Anthony J, Cicardi, Marco, Davis, Alvin E, De Carolis, Caterina, Drouet, Christian, Duponchel, Christiane, Farkas, Henriette, Fáy, Kálmán, Fekete, Béla, Fischer, Bettina, Fontana, Luigi, Füst, George, Giacomelli, Roberto, Gröner, Albrecht, Erik Hack, C., Harmat, George, Jakenfelds, John, Juers, Mathias, Kalmár, Lajos, Kaposi, Pál N., Karádi, István, Kitzinger, Arianna, Kollár, Tímea, Kreuz, Wolfhart, Lakatos, Peter, Longhurst, Hilary J., Lopez-Trascasa, Margarita, Martinez-Saguer, Inmaculada, Monnier, Nicole, Nagy, István, Németh, Éva, Nielsen, Erik Waage, Nuijens, Jan H., O'Grady, Caroline, Pappalardo, Emanuela, Penna, Vincenzo, Perricone, Carlo, Perricone, Roberto, Rauch, Ursula, Roche, Olga, Rusicke, Eva, Späth, Peter J, Szendei, George, Takács, Edit, Tordai, Attila, Truedsson, Lennart, Varga, Lilian, Visy, Beáta, Williams, Kayla, Zanichelli, Andrea, Zingale, Lorenza · 2004 · Journal of Allergy and Clinical Immunology

Abstract

Hereditary angioedema (HAE), a rare but life-threatening condition, manifests as acute attacks of facial, laryngeal, genital, or peripheral swelling or abdominal pain secondary to intra-abdominal edema. Resulting from mutations affecting C1 esterase inhibitor (C1-INH), inhibitor of the first complement system component, attacks are not histamine-mediated and do not respond to antihistamines or corticosteroids. Low awareness and resemblance to other disorders often delay diagnosis; despite availability of C1-INH replacement in some countries, no approved, safe acute attack therapy exists in the United States. The biennial C1 Esterase Inhibitor Deficiency Workshops resulted from a European initiative for better knowledge and treatment of HAE and related diseases. This supplement contains work presented at the third workshop and expanded content toward a definitive picture of angioedema in the absence of allergy. Most notably, it includes cumulative genetic investigations; multinational laboratory diagnosis recommendations; current pathogenesis hypotheses; suggested prophylaxis and acute attack treatment, including home treatment; future treatment options; and analysis of patient subpopulations, including pediatric patients and patients whose angioedema worsened during pregnancy or hormone administration. Causes and management of acquired angioedema and a new type of angioedema with normal C1-INH are also discussed. Collaborative patient and physician efforts, crucial in rare diseases, are emphasized. This supplement seeks to raise awareness and aid diagnosis of HAE, optimize treatment for all patients, and provide a platform for further research in this rare, partially understood disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2004.06.047

Cites

216 of 216 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 201–216 of 216

Research works printed but not linked: 241

  1. Dennehy, 1970, Hereditary angioneurotic edema: report of a large kindred with defect in C'1 esterase inhibitor and review of the literature, Ann Intern Med, 73, 55, 10.7326/0003-4819-73-1-55 · doi:10.7326/0003-4819-73-1-55
  2. Milton, 1876, On giant urticaria, Edinburgh Med J, 22, 513
  3. Quincke, 1882, Über akutes umschriebenes Hautödem [About an acute described skin edema], Monatshe Prakt Dermatol, 1, 129
  4. Luong, 1997, Complement abnormalities with lower extremities discomfort in Vietnamese immigrants, Allergy Asthma Proc, 18, 239, 10.2500/108854197778594098 · doi:10.2500/108854197778594098
  5. Bossi, 2004, Endothelial cells contribute to vascular leakage in patients with C1 inhibitor deficiency and angioedema, Mol Immunol, 41, 212
  6. Frank, 1979, Effect of sex hormones on the complement-related clinical disorder of hereditary angioedema, Arthritis Rheum, 22, 1295, 10.1002/art.1780221118 · doi:10.1002/art.1780221118
  7. Boeckers, 1987, [Contraception and pregnancy in hereditary angioedema], Dtsch Med Wochenschr, 112, 507
  8. Wautier, 1986, [Norgestrienone, a possible therapeutic agent in hereditary angioneurotic edema], Presse Med, 15, 2023
  9. Nielsen, 1996, Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses, J Intern Med, 239, 119, 10.1046/j.1365-2796.1996.418764000.x · doi:10.1046/j.1365-2796.1996.418764000.x
  10. Laurent, 1987, [Hereditary angioneurotic edema: norgestrienone is not effective in every case], Presse Med, 16, 2132
  11. Hadjiyannaki, 1971, Hereditary angio-oedema: a review with particular reference to pathogenesis and treatment, Clin Allergy, 1, 221, 10.1111/j.1365-2222.1971.tb03021.x · doi:10.1111/j.1365-2222.1971.tb03021.x
  12. Winnewisser, 1997, Type I hereditary angio-oedema: variability of clinical presentation and course within two large kindreds, J Intern Med, 241, 39, 10.1046/j.1365-2796.1997.76893000.x · doi:10.1046/j.1365-2796.1997.76893000.x
  13. Bork, 1998, [Hypovolemic shock caused by ascites in hereditary angioedema], Med Klin (Munich), 93, 554, 10.1007/BF03042666 · doi:10.1007/bf03042666
  14. Cohen, 1993, Hereditary angioneurotic edema with severe hypovolemic shock, J Clin Gastroenterol, 16, 237, 10.1097/00004836-199304000-00016 · doi:10.1097/00004836-199304000-00016
  15. Talavera, 1995, Hereditary angioedema: an infrequent cause of abdominal pain with ascites, Am J Gastroenterol, 90, 471
  16. Dinkel, 2001, Sonographic appearances of the abdominal manifestations of hereditary angioedema, Pediatr Radiol, 31, 296, 10.1007/s002470000409 · doi:10.1007/s002470000409
  17. Campanile, 2001, Changes in splenoportal axis calibre and flow in a patient affected by hereditary angioedema, Panminerva Med, 43, 307
  18. Sofia, 1999, Sonographic findings in abdominal hereditary angioedema, J Clin Ultrasound, 27, 537, 10.1002/(SICI)1097-0096(199911/12)27:9<537::AID-JCU9>3.0.CO;2-L · doi:10.1002/(sici)1097-0096(199911/12)27:9<537::aid-jcu9>3.0.co;2-l
  19. Wong, 1999, Image of the month: hereditary angioedema (HAE), Gastroenterology, 116, 514, 10.1016/S0016-5085(99)70170-8 · doi:10.1016/s0016-5085(99)70170-8
  20. Hara, 1999, Hereditary angioedema with gastrointestinal involvement: endoscopic appearance, Endoscopy, 31, 322, 10.1055/s-1999-14 · doi:10.1055/s-1999-14
  21. Calbo, 1992, Abdominal attack of hereditary angioedema associated with marked leucocytosis: a case report, Ital J Gastroenterol, 24, 464
  22. Wüthrich, 1999, [Hereditary or acquired angioedema caused by functional deficiency of C1 inhibitor–a still unfamiliar disease picture], Schweiz Med Wochenschr, 129, 285
  23. Bork, 2000, Asphyxiation by laryngeal edema in patients with hereditary angioedema, Mayo Clin Proc, 75, 349, 10.4065/75.4.349 · doi:10.4065/75.4.349
  24. Bork, 2001, Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema, Arch Intern Med, 161, 714, 10.1001/archinte.161.5.714 · doi:10.1001/archinte.161.5.714
  25. Farkas, 2001, Erythema marginatum preceding an acute oedematous attack of hereditary angioneurotic oedema, Acta Derm Venereol, 81, 376, 10.1080/000155501317140188 · doi:10.1080/000155501317140188
  26. Legendre, 1985, [Respiratory manifestations in hereditary angioneurotic edema], Rev Pneumol Clin, 41, 251
  27. Van Dellen, 1980, Bladder involvement in hereditary angioedema, Mayo Clin Proc, 55, 277
  28. Sunder, 1982, Neurological manifestations of angioedema: report of two cases and review of the literature, JAMA, 247, 2005, 10.1001/jama.1982.03320390067048 · doi:10.1001/jama.1982.03320390067048
  29. Krause, 1979, [Cerebral manifestations in angioneurotic edema (author's translation)], J Neurol Sci, 42, 429, 10.1016/0022-510X(79)90175-8 · doi:10.1016/0022-510x(79)90175-8
  30. Landerman, 1962, Hereditary angioneurotic edema, I: case reports and review of the literature, J Allergy, 33, 316, 10.1016/0021-8707(62)90031-X · doi:10.1016/0021-8707(62)90031-x
  31. Farkas, 2001, Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema, Lancet, 358, 1695, 10.1016/S0140-6736(01)06720-4 · doi:10.1016/s0140-6736(01)06720-4
  32. Iamandescu, 1990, Contributions to the study of the favouring role of chronic urinary infections in inducing and starting drug-allergic-type reactions, Med Interne, 28, 53
  33. Watson, 2000, Acquired angioedema associated with sinusitis, J Investig Allergol Clin Immunol, 10, 129
  34. Wedi, 1999, Helicobacter pylori infection and skin diseases, J Physiol Pharmacol, 50, 753
  35. Gudat, 1989, Hereditary angioedema associated with subacute cutaneous lupus erythematosus, Dermatologica, 179, 211, 10.1159/000248363 · doi:10.1159/000248363
  36. Duncan, 1988, Rheumatoid arthritis and hereditary angioedema, J Rheumatol, 15, 700
  37. Brickman, 1986, Immunoregulatory disorders associated with hereditary angioedema, II: serologic and cellular abnormalities, J Allergy Clin Immunol, 77, 758, 10.1016/0091-6749(86)90425-2 · doi:10.1016/0091-6749(86)90425-2
  38. Sturfelt, 1996, C1 inhibitor deficiency in a patient with rheumatoid arthritis—increased risk of adverse effects of penicillamine?, J Rheumatol, 23, 378
  39. Hory, 1989, Glomerulonephritis and hereditary angioedema: report of 2 cases, Clin Nephrol, 31, 259
  40. Pan, 1992, Long-term follow-up of non-systemic lupus erythematosus glomerulonephritis in patients with hereditary angioedema: report of four cases, Am J Kidney Dis, 19, 526, 10.1016/S0272-6386(12)80830-4 · doi:10.1016/s0272-6386(12)80830-4
  41. Alper, 1987, Inherited deficiencies of complement components in man, Immunol Lett, 14, 175, 10.1016/0165-2478(87)90098-8 · doi:10.1016/0165-2478(87)90098-8
  42. Fernandez, 1978, Hereditary angioneurotic edema and Charcot-Marie-Tooth disease in the same family, Can Med Assoc J, 119, 455
  43. Farkas, 2002, Association of celiac disease and hereditary angioneurotic edema, Am J Gastroenterol, 97, 2682, 10.1111/j.1572-0241.2002.06059.x · doi:10.1111/j.1572-0241.2002.06059.x
  44. Farkas, 1999, Coincidence of hereditary angioedema (HAE) with Crohn's disease, Immunol Invest, 28, 43, 10.3109/08820139909022722 · doi:10.3109/08820139909022722
  45. Cicardi, 1995, Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate, Transfusion, 35, 209, 10.1046/j.1537-2995.1995.35395184276.x · doi:10.1046/j.1537-2995.1995.35395184276.x
  46. Laurent, 1988, Ultrasonography in the diagnosis of hereditary angioneurotic oedema, Lancet, 1, 761, 10.1016/S0140-6736(88)91558-9 · doi:10.1016/s0140-6736(88)91558-9
  47. Burghardt, 1987, Ultrasonography for early diagnosis of hereditary angioneurotic oedema, Lancet, 2, 165, 10.1016/S0140-6736(87)92371-3 · doi:10.1016/s0140-6736(87)92371-3
  48. Farkas, 2001, Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema, Eur J Gastroenterol Hepatol, 13, 1225, 10.1097/00042737-200110000-00016 · doi:10.1097/00042737-200110000-00016
  49. Farkas, 2002, Clinical management of hereditary angio-oedema in children, Pediatr Allergy Immunol, 13, 153, 10.1034/j.1399-3038.2002.01014.x · doi:10.1034/j.1399-3038.2002.01014.x
  50. Farkas, 2002, Acute abdominal attack of hereditary angioneurotic oedema associated with ultrasound abnormalities suggestive of acute hepatitis, Acta Paediatr, 91, 971, 10.1111/j.1651-2227.2002.tb02864.x · doi:10.1111/j.1651-2227.2002.tb02864.x
  51. Bowen, 2001, A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations, Clin Immunol, 98, 157, 10.1006/clim.2000.4947 · doi:10.1006/clim.2000.4947
  52. Martin, 2001, Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission, J Allergy Clin Immunol, 107, 747, 10.1067/mai.2001.114242 · doi:10.1067/mai.2001.114242
  53. Verpy, 1995, Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function, J Clin Invest, 95, 350, 10.1172/JCI117663 · doi:10.1172/jci117663
  54. Binkley, 2003, Estrogen-dependent inherited angioedema, Transfus Apheresis Sci, 29, 215, 10.1016/j.transci.2003.08.002 · doi:10.1016/j.transci.2003.08.002
  55. Binkley, 1996, Exacerbation of angioedema by an angiotensin converting enzyme inhibitor in a patient with variant form hereditary angioedema, Can J Allergy Clin Immunol, 1, 134
  56. Binkley, 2001, Reply (Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission), J Allergy Clin Immunol, 107, 747, 10.1067/mai.2001.114243 · doi:10.1067/mai.2001.114243
  57. Kranke, 2000, Hereditary angioedema and normal C1-inhibitor activity in women, Lancet, 356, 1440, 10.1016/S0140-6736(05)74078-2 · doi:10.1016/s0140-6736(05)74078-2
  58. Sheffer, 1987, Hereditary angioedema: a decade of management with stanozolol, J Allergy Clin Immunol, 80, 855, 10.1016/S0091-6749(87)80277-4 · doi:10.1016/s0091-6749(87)80277-4
  59. Gordon, 1980, Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives, J Lab Clin Med, 96, 762
  60. Ogston, 1981, C1 inactivator level in pregnancy, Thromb Res, 23, 453, 10.1016/0049-3848(81)90206-1 · doi:10.1016/0049-3848(81)90206-1
  61. Halbmayer, 1991, C1-esterase inhibitor in uncomplicated pregnancy and mild and moderate preeclampsia, Thromb Haemost, 65, 134, 10.1055/s-0038-1647471 · doi:10.1055/s-0038-1647471
  62. Cohen, 1992, C1 esterase inhibitor in pregnancy, J Allergy Clin Immunol, 90, 412, 10.1016/S0091-6749(05)80025-9 · doi:10.1016/s0091-6749(05)80025-9
  63. Melamed, 1986, The metabolism of C1 inhibitor and C1q in patients with acquired C1-inhibitor deficiency, J Allergy Clin Immunol, 77, 322, 10.1016/S0091-6749(86)80111-7 · doi:10.1016/s0091-6749(86)80111-7
  64. Cicardi, 1993, Autoimmune C1 inhibitor deficiency: report of eight patients, Am J Med, 95, 169, 10.1016/0002-9343(93)90257-P · doi:10.1016/0002-9343(93)90257-p
  65. Hauptmann, 1979, Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen: reversal of complement abnormalities after splenectomy, Clin Exp Immunol, 37, 523
  66. Cicardi, 1985, Acquired C1 inhibitor deficiency with angioedema symptoms in a patient infected with Echinococcus granulosus, Complement, 2, 133, 10.1159/000467853 · doi:10.1159/000467853
  67. Farkas, 1999, Acquired angioedema associated with chronic hepatitis C, J Allergy Clin Immunol, 103, 711, 10.1016/S0091-6749(99)70248-4 · doi:10.1016/s0091-6749(99)70248-4
  68. Farkas, 1999, Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection, Z Gastroenterol, 37, 513
  69. Farkas, 2001, Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis, Acta Derm Venereol, 81, 298, 10.1080/00015550152572985 · doi:10.1080/00015550152572985
  70. Sheffer, 1985, Acquired deficiency of the inhibitor of the first component of complement: report of five additional cases with commentary on the syndrome, J Allergy Clin Immunol, 75, 640, 10.1016/0091-6749(85)90087-9 · doi:10.1016/0091-6749(85)90087-9
  71. Pascual, 1987, Recurrent febrile panniculitis and hepatitis in two patients with acquired complement deficiency and paraproteinemia, Am J Med, 83, 959, 10.1016/0002-9343(87)90659-0 · doi:10.1016/0002-9343(87)90659-0
  72. Frigas, 1989, Angioedema with acquired deficiency of the C1 inhibitor: a constellation of syndromes, Mayo Clin Proc, 64, 1269, 10.1016/S0025-6196(12)61290-7 · doi:10.1016/s0025-6196(12)61290-7
  73. Alsenz, 1989, Acquired C1 inhibitor (C1-INH) deficiency type II: replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies, J Clin Invest, 83, 1794, 10.1172/JCI114084 · doi:10.1172/jci114084
  74. Whaley, 1996, Autoimmune C1-inhibitor deficiency, Clin Exp Immunol, 106, 423, 10.1046/j.1365-2249.1996.d01-879.x · doi:10.1046/j.1365-2249.1996.d01-879.x
  75. D'Incan, 1999, Acquired angioedema with C1 inhibitor deficiency: is the distinction between type I and type II still relevant?, Dermatology, 199, 227, 10.1159/000018252 · doi:10.1159/000018252
  76. Fremeaux-Bacchi, 2002, Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2, Am J Med, 113, 194, 10.1016/S0002-9343(02)01124-5 · doi:10.1016/s0002-9343(02)01124-5
  77. Bouillet-Claveyrolas, 2003, Clinical and biological distinctions between type I and type II acquired angioedema, Am J Med, 115, 420, 10.1016/S0002-9343(03)00396-6 · doi:10.1016/s0002-9343(03)00396-6
  78. Cicardi, 2003, Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies, Medicine (Baltimore), 82, 274, 10.1097/01.md.0000085055.63483.09 · doi:10.1097/01.md.0000085055.63483.09
  79. Sim, 1979, Interaction of 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma, FEBS Lett, 97, 111, 10.1016/0014-5793(79)80063-0 · doi:10.1016/0014-5793(79)80063-0
  80. de Agostini, 1984, Inactivation of factor XII active fragment in normal plasma: predominant role of C-1-inhibitor, J Clin Invest, 73, 1542, 10.1172/JCI111360 · doi:10.1172/jci111360
  81. Theriault, 1990, Regional assignment of the human C1-inhibitor gene to 11q11-q13.1, Hum Genet, 84, 477, 10.1007/BF00195824 · doi:10.1007/bf00195824
  82. Janson, 1991, Detailed physical map of human chromosomal region 11q12-13 shows high meiotic recombination rate around the MEN1 locus, Proc Natl Acad Sci U S A, 88, 10609, 10.1073/pnas.88.23.10609 · doi:10.1073/pnas.88.23.10609
  83. Carter, 1991, Complete nucleotide sequence of the gene for human C1 inhibitor with an unusually high density of Alu elements, Eur J Biochem, 197, 301, 10.1111/j.1432-1033.1991.tb15911.x · doi:10.1111/j.1432-1033.1991.tb15911.x
  84. Ariga, 1990, Recombinations between Alu repeat sequences that result in partial deletions within the C1 inhibitor gene, Genomics, 8, 607, 10.1016/0888-7543(90)90246-Q · doi:10.1016/0888-7543(90)90246-q
  85. Stoppa-Lyonnet, 1991, Recombinational biases in the rearranged C1-inhibitor genes of hereditary angioedema patients, Am J Hum Genet, 49, 1055
  86. Eldering, 1995, COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization, J Biol Chem, 270, 2579, 10.1074/jbc.270.6.2579 · doi:10.1074/jbc.270.6.2579
  87. Davis, 1997, C1 inhibitor. Functional analysis of naturally-occurring mutant proteins, Adv Exp Med Biol, 425, 185, 10.1007/978-1-4615-5391-5_18 · doi:10.1007/978-1-4615-5391-5_18
  88. Aulak, 1993, A hinge region mutation in C1-inhibitor (Ala436–Thr) results in nonsubstrate-like behavior and in polymerization of the molecule, J Biol Chem, 268, 18088, 10.1016/S0021-9258(17)46815-3 · doi:10.1016/s0021-9258(17)46815-3
  89. Bos, 2002, Structural and functional aspects of C1-inhibitor, Immunobiology, 205, 518, 10.1078/0171-2985-00151 · doi:10.1078/0171-2985-00151
  90. Bissler, 1998, C1 inhibitor gene sequence facilitates frameshift mutations, Mol Med, 4, 795, 10.1007/BF03401772 · doi:10.1007/bf03401772
  91. Ellis, 1998, Chemical cleavage of mismatch: a new look at an established method, Hum Mutat, 11, 345, 10.1002/(SICI)1098-1004(1998)11:5<345::AID-HUMU1>3.0.CO;2-0 · doi:10.1002/(sici)1098-1004(1998)11:5<345::aid-humu1>3.0.co;2-0
  92. Verpy, 1993, C1 inhibitor mutations which affect intracellular transport and secretion in type I hereditary angioedema, Behring Inst Mitt, 120
  93. Cotton, 1993, Current methods of mutation detection, Mutat Res, 285, 125, 10.1016/0027-5107(93)90060-S · doi:10.1016/0027-5107(93)90060-s
  94. Verpy, 1994, Efficient detection of point mutations on color-coded strands of target DNA, Proc Natl Acad Sci U S A, 91, 1873, 10.1073/pnas.91.5.1873 · doi:10.1073/pnas.91.5.1873
  95. Freiberger, 2002, Five novel mutations in the C1 inhibitor gene (C1NH) leading to a premature stop codon in patients with type I hereditary angioedema, Hum Mutat, 19, 461, 10.1002/humu.9029 · doi:10.1002/humu.9029
  96. McPhaden, 1991, Restriction fragment length polymorphism analysis of the C1-inhibitor gene in hereditary C1-inhibitor deficiency, Clin Genet, 39, 161, 10.1111/j.1399-0004.1991.tb03006.x · doi:10.1111/j.1399-0004.1991.tb03006.x
  97. Duponchel, 2001, Rapid detection by fluorescent multiplex PCR of exon deletions and duplications in the C1 inhibitor gene of hereditary angioedema patients, Hum Mutat, 17, 61, 10.1002/1098-1004(2001)17:1<61::AID-HUMU7>3.0.CO;2-9 · doi:10.1002/1098-1004(2001)17:1<61::aid-humu7>3.0.co;2-9
  98. Cumming, 2003, The effect of sequence variations within the coding region of the C1 inhibitor gene on disease expression and protein function in families with hereditary angio-oedema, J Med Genet, 40, e114, 10.1136/jmg.40.10.e114 · doi:10.1136/jmg.40.10.e114
  99. Zahedi, 1999, The promoter of the C1 inhibitor gene contains a polypurine-polypyrimidine segment that enhances transcriptional activity, J Immunol, 162, 7249, 10.4049/jimmunol.162.12.7249 · doi:10.4049/jimmunol.162.12.7249
  100. Sugiyama, 2001, Hereditary angioedema with a de novo mutation of exon 8 in the C1 inhibitor gene showing recurrent edema of the hands around the peripheral joints: importance for the differential diagnosis of joint swelling, Arthritis Rheum, 44, 974, 10.1002/1529-0131(200104)44:4<974::AID-ANR155>3.0.CO;2-1 · doi:10.1002/1529-0131(200104)44:4<974::aid-anr155>3.0.co;2-1
  101. Eldering, 1988, Expression of functional human C1 inhibitor in COS cells, J Biol Chem, 263, 11776, 10.1016/S0021-9258(18)37851-7 · doi:10.1016/s0021-9258(18)37851-7
  102. Eldering, 1992, Characterization of recombinant C1 inhibitor P1 variants, J Biol Chem, 267, 7013, 10.1016/S0021-9258(19)50529-4 · doi:10.1016/s0021-9258(19)50529-4
  103. Salvesen, 1985, Primary structure of the reactive site of human C1-inhibitor, J Biol Chem, 260, 2432, 10.1016/S0021-9258(18)89572-2 · doi:10.1016/s0021-9258(18)89572-2
  104. Tosi, 1986, Molecular cloning of human C1 inhibitor: sequence homologies with alpha 1-antitrypsin and other members of the serpins superfamily, Gene, 42, 265, 10.1016/0378-1119(86)90230-1 · doi:10.1016/0378-1119(86)90230-1
  105. Cugno, 2001, In vitro interaction of C1-inhibitor with thrombin, Blood Coagul Fibrinolysis, 12, 253, 10.1097/00001721-200106000-00005 · doi:10.1097/00001721-200106000-00005
  106. Harpel, 1970, C1 inactivator inhibition by plasmin, J Clin Invest, 49, 568, 10.1172/JCI106267 · doi:10.1172/jci106267
  107. Wuillemin, 1997, Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma, J Immunol, 159, 1953, 10.4049/jimmunol.159.4.1953 · doi:10.4049/jimmunol.159.4.1953
  108. Wuillemin, 1996, Modulation of contact system proteases by glycosaminoglycans: selective enhancement of the inhibition of factor XIa, J Biol Chem, 271, 12913, 10.1074/jbc.271.22.12913 · doi:10.1074/jbc.271.22.12913
  109. Bos, 2001, The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model, Int Immunopharmacol, 1, 1583, 10.1016/S1567-5769(01)00073-X · doi:10.1016/s1567-5769(01)00073-x
  110. Bos, 2003, The functional integrity of the serpin domain of C1-inhibitor depends on the unique N-terminal domain, as revealed by a pathological mutant, J Biol Chem, 278, 29463, 10.1074/jbc.M302977200 · doi:10.1074/jbc.m302977200
  111. Woo, 1985, Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases, Clin Exp Immunol, 61, 1
  112. Minta, 1981, The role of sialic acid in the functional activity and the hepatic clearance of C1-INH, J Immunol, 126, 245, 10.4049/jimmunol.126.1.245 · doi:10.4049/jimmunol.126.1.245
  113. de Smet, 1993, Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats, Blood, 81, 56, 10.1182/blood.V81.1.56.56 · doi:10.1182/blood.v81.1.56.56
  114. Milgrom, 1980, Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4, J Immunol, 124, 2780, 10.4049/jimmunol.124.6.2780 · doi:10.4049/jimmunol.124.6.2780
  115. Wuillemin, 1996, Inactivation of factor XIa in vivo: studies in chimpanzees and in humans, Thromb Haemost, 76, 549, 10.1055/s-0038-1650621 · doi:10.1055/s-0038-1650621
  116. Hack, 1998, The role of factor XII in contact system activation, Blood, 92, 703, 10.1182/blood.V92.2.703 · doi:10.1182/blood.v92.2.703
  117. Strang, 1988, Angioedema induced by a peptide derived from complement component C2, J Exp Med, 168, 1685, 10.1084/jem.168.5.1685 · doi:10.1084/jem.168.5.1685
  118. Griep, 1985, Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles, Biochemistry, 24, 4124, 10.1021/bi00336a047 · doi:10.1021/bi00336a047
  119. Schousboe, 1994, Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII, Blood Coagul Fibrinolysis, 5, 503
  120. Dumenco, 1988, Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4, J Lab Clin Med, 112, 394
  121. Agostoni, 2002, [Vasopeptidases and their inhibitors], Recenti Prog Med, 93, 519
  122. La Rocca, 1986, [Hereditary angioedema: genealogic studies and clinical considerations on 2 genetic forms in a case study of 10 patients], G Ital Dermatol Venereol, 121, 203
  123. Pavletic, 2002, Late angioedema caused by ACE inhibitors underestimated, Am Fam Physician, 66, 956
  124. Chiu, 2001, Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology, Laryngoscope, 111, 1729, 10.1097/00005537-200110000-00011 · doi:10.1097/00005537-200110000-00011
  125. Tan, 2004, Mechanisms of angiotensin II-induced expression of B2 kinin receptors, Am J Physiol Heart Circ Physiol, 286, H926, 10.1152/ajpheart.00757.2003 · doi:10.1152/ajpheart.00757.2003
  126. Ruschitzka, 2001, Vasopeptidase inhibitors—concepts and evidence, Nephrol Dial Transplant, 16, 1532, 10.1093/ndt/16.8.1532 · doi:10.1093/ndt/16.8.1532
  127. Mathews, 1986, Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency, J Clin Immunol, 6, 87, 10.1007/BF00915368 · doi:10.1007/bf00915368
  128. Rojkjaer, 1998, Factor XII does not initiate prekallikrein activation on endothelial cells, Thromb Haemost, 80, 74, 10.1055/s-0037-1615142 · doi:10.1055/s-0037-1615142
  129. Schmaier, 2004, The physiologic basis of assembly and activation of the plasma kallikrein/kinin system, Thromb Haemost, 91, 1, 10.1055/s-0037-1614255 · doi:10.1055/s-0037-1614255
  130. Gordon, 1988, Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII, J Lab Clin Med, 111, 52
  131. Jespersen, 1985, Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen—levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator, Thromb Haemost, 54, 454, 10.1055/s-0038-1657871 · doi:10.1055/s-0038-1657871
  132. Fossum, 1994, Contact factors in plasma from women on oral contraception—significance of factor XI for the measured activity of factor XII, Thromb Res, 74, 477, 10.1016/0049-3848(94)90268-2 · doi:10.1016/0049-3848(94)90268-2
  133. Farmer, 1992, Biochemical and molecular pharmacology of kinin receptors, Annu Rev Pharmacol Toxicol, 32, 511, 10.1146/annurev.pa.32.040192.002455 · doi:10.1146/annurev.pa.32.040192.002455
  134. Fletcher, 1998, Coexistence of hereditary angioedema and Turner's syndrome, Postgrad Med J, 74, 41, 10.1136/pgmj.74.867.41 · doi:10.1136/pgmj.74.867.41
  135. Citarella, 1996, Estrogen induction and contact phase activation of human factor XII, Steroids, 61, 270, 10.1016/0039-128X(96)00037-2 · doi:10.1016/0039-128x(96)00037-2
  136. Campbell, 1993, Contact factor mediated fibrinolysis is increased by the combined oral contraceptive pill, Br J Obstet Gynaecol, 100, 79, 10.1111/j.1471-0528.1993.tb12956.x · doi:10.1111/j.1471-0528.1993.tb12956.x
  137. Visy, 2004, Sex hormones in hereditary angioneurotic oedema, Clin Endocrinol (Oxf), 60, 508, 10.1111/j.1365-2265.2004.02009.x · doi:10.1111/j.1365-2265.2004.02009.x
  138. Borradori, 1990, Hereditary angioedema and oral contraception, Dermatologica, 181, 78, 10.1159/000247874 · doi:10.1159/000247874
  139. Munkvad, 1990, Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma, Clin Chem, 36, 737, 10.1093/clinchem/36.5.737 · doi:10.1093/clinchem/36.5.737
  140. Nielsen, 1994, Effect of time, temperature and additives on a functional assay of C1 inhibitor, J Immunol Methods, 173, 245, 10.1016/0022-1759(94)90303-4 · doi:10.1016/0022-1759(94)90303-4
  141. Grattan, 2001, Management and diagnostic guidelines for urticaria and angio-oedema, Br J Dermatol, 144, 708, 10.1046/j.1365-2133.2001.04175.x · doi:10.1046/j.1365-2133.2001.04175.x
  142. Blohme, 1972, Hereditary angioneurotic oedema in three families: symptomatic heterogeneity, complement analysis and therapeutic trials, Acta Med Scand, 191, 209
  143. Ohela, 1977, Hereditary angioneurotic oedema in Finland: clinical, immunological and genealogical studies, Acta Med Scand, 201, 415, 10.1111/j.0954-6820.1977.tb15724.x · doi:10.1111/j.0954-6820.1977.tb15724.x
  144. Zeana, 1989, Hereditary angioedema due to deficit of C1 esterase inhibitor, Med Interne, 27, 143
  145. Donaldson, 1966, Hereditary angioneurotic edema: a clinical survey, Pediatrics, 37, 1017, 10.1542/peds.37.6.1017 · doi:10.1542/peds.37.6.1017
  146. Madalinski, 1991, C1-INH defect as an example of deficiency disease, Immunol Invest, 20, 133, 10.3109/08820139109050781 · doi:10.3109/08820139109050781
  147. Barakat, 1993, Hereditary angioedema: danazol therapy in a 5-year-old child, Am J Dis Child, 147, 931
  148. Cox, 1995, Hereditary angioneurotic oedema: current management in pregnancy, Anaesthesia, 50, 547, 10.1111/j.1365-2044.1995.tb06050.x · doi:10.1111/j.1365-2044.1995.tb06050.x
  149. Gompels, 2002, A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency, J Clin Pathol, 55, 145, 10.1136/jcp.55.2.145 · doi:10.1136/jcp.55.2.145
  150. Matter, 1981, [Hereditary angioedema: description of a sibship and review], Schweiz Med Wochenschr, 111, 1238
  151. Nielsen, 1995, C3 is activated in hereditary angioedema, and C1/C1-inhibitor complexes rise during physical stress in untreated patients, Scand J Immunol, 42, 679, 10.1111/j.1365-3083.1995.tb03711.x · doi:10.1111/j.1365-3083.1995.tb03711.x
  152. Sonntag, 1997, Contact system in healthy term newborns: reference values in cord blood, Thromb Res, 87, 339, 10.1016/S0049-3848(97)00136-9 · doi:10.1016/s0049-3848(97)00136-9
  153. Wolbink, 1993, Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway, J Immunol Methods, 163, 67, 10.1016/0022-1759(93)90240-8 · doi:10.1016/0022-1759(93)90240-8
  154. Nielsen, 1994, C1 inhibitor and diagnosis of hereditary angioedema in newborns, Pediatr Res, 35, 184, 10.1203/00006450-199402000-00012 · doi:10.1203/00006450-199402000-00012
  155. Ferlazzo, 1991, [Determination of complement proteins in the umbilical cord in the early diagnosis of hereditary angioneurotic edema], Recenti Prog Med, 82, 29
  156. Spath, 1990, Angioedema: a review on the acquired, allergic or non-allergic, and the hereditary forms, Recenti Prog Med, 81, 513
  157. Davis, 1979, Serum complement levels in infancy: age related changes, Pediatr Res, 13, 1043, 10.1203/00006450-197909000-00019 · doi:10.1203/00006450-197909000-00019
  158. Intrator, 1985, [Complement fractions in cord blood: value for the neonatal detection of hereditary angioneurotic edema], Presse Med, 14, 1668
  159. Andrew, 1983, Plasma protease inhibitors in premature infants: influence of gestational age, postnatal age, and health status, Proc Soc Exp Biol Med, 173, 495, 10.3181/00379727-173-41676 · doi:10.3181/00379727-173-41676
  160. Norman, 1975, Serum complement profiles in infants and children, J Pediatr, 87, 912, 10.1016/S0022-3476(75)80904-8 · doi:10.1016/s0022-3476(75)80904-8
  161. Gompels, 2003, Misdiagnosis of hereditary angio-oedema type 1 and type 2, Br J Dermatol, 148, 719, 10.1046/j.1365-2133.2003.05231.x · doi:10.1046/j.1365-2133.2003.05231.x
  162. Zuraw, 1991, Acute consumption of C1 inhibitor in a patient with acquired C1-inhibitor deficiency syndrome, J Allergy Clin Immunol, 88, 908, 10.1016/0091-6749(91)90248-M · doi:10.1016/0091-6749(91)90248-m
  163. Karim, 2004, Normal complement C4 values do not exclude hereditary angioedema, J Clin Pathol, 57, 213, 10.1136/jcp.2003.12021 · doi:10.1136/jcp.2003.12021
  164. Gadek, 1980, Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor, N Engl J Med, 302, 542, 10.1056/NEJM198003063021002 · doi:10.1056/nejm198003063021002
  165. Bergamaschini, 1983, C1 INH concentrate in the therapy of hereditary angioedema, Allergy, 38, 81, 10.1111/j.1398-9995.1983.tb01590.x · doi:10.1111/j.1398-9995.1983.tb01590.x
  166. Visentin, 1998, C1-esterase inhibitor transfusions in patients with hereditary angioedema, Ann Allergy Asthma Immunol, 80, 457, 10.1016/S1081-1206(10)63067-0 · doi:10.1016/s1081-1206(10)63067-0
  167. Pickering, 1969, Replacement therapy in hereditary angioedema: successful treatment of two patients with fresh frozen plasma, Lancet, 1, 326, 10.1016/S0140-6736(69)91295-1 · doi:10.1016/s0140-6736(69)91295-1
  168. Carugati, 2001, C1-inhibitor deficiency and angioedema, Mol Immunol, 38, 161, 10.1016/S0161-5890(01)00040-2 · doi:10.1016/s0161-5890(01)00040-2
  169. Marasini, 1978, Treatment of hereditary angioedema, Klin Wochenschr, 56, 819, 10.1007/BF01489716 · doi:10.1007/bf01489716
  170. Proud, 1976, Letter: anaphylactic reaction to aprotinin, Lancet, 2, 48, 10.1016/S0140-6736(76)93012-9 · doi:10.1016/s0140-6736(76)93012-9
  171. Gonzales-Quevado, 2002, The synthetic Kunitz domain protein DX-88 to treat angioedema in patients with hereditary angioedema, Int Immunopharmacol, 2, 1318
  172. Jerini announces positive phase II study results with Icatibant for the treatment of Hereditary Angioedema [press release]. Berlin: Jerini Pharmaceuticals; January 13, 2004
  173. Nuijens, 2002, A phase I study of recombinant human C1-INH in asymptomatic patients with hereditary angioedema-HAE, Int Immunopharmacol, 2, 1315
  174. Pharming features clinical results of C1 inhibitor at investigator meeting [press release]. Leiden: Pharming; January 19, 2004
  175. Cicardi, 1991, Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience, J Allergy Clin Immunol, 87, 768, 10.1016/0091-6749(91)90120-D · doi:10.1016/0091-6749(91)90120-d
  176. Crampon, 1998, Danazol therapy: an unusual aetiology of hepatocellular carcinoma, J Hepatol, 29, 1035, 10.1016/S0168-8278(98)80140-2 · doi:10.1016/s0168-8278(98)80140-2
  177. Bork, 1999, Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema, Lancet, 353, 1066, 10.1016/S0140-6736(99)00110-5 · doi:10.1016/s0140-6736(99)00110-5
  178. Bork, 2002, Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema, J Hepatol, 36, 707, 10.1016/S0168-8278(02)00035-1 · doi:10.1016/s0168-8278(02)00035-1
  179. Lundh, 1968, A case of hereditary angioneurotic oedema, successfully treated with epsilon-aminocaproic acid: studies on C'1 esterase inhibitor, C'1 activation, plasminogen level and histamine metabolism, Clin Exp Immunol, 3, 733
  180. Bork, 1989, Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency, J Allergy Clin Immunol, 83, 677, 10.1016/0091-6749(89)90082-1 · doi:10.1016/0091-6749(89)90082-1
  181. Martinez-Saguer, 2002, Pharmacokinetic parameters of C1-inhibitor concentrate in 40 patients with hereditary angio-oedema (HAE)—a prospective study, Haemophilia, 8, 574
  182. Degroote, 1985, Acute airway obstruction following tooth extraction in hereditary angioedema, J Oral Maxillofac Surg, 43, 52, 10.1016/S0278-2391(85)80014-8 · doi:10.1016/s0278-2391(85)80014-8
  183. Atkinson, 1991, Oral manifestations and dental management of patients with hereditary angioedema, J Oral Pathol Med, 20, 139, 10.1111/j.1600-0714.1991.tb00908.x · doi:10.1111/j.1600-0714.1991.tb00908.x
  184. Phillips, 1989, Hereditary angioedema: report of case, Spec Care Dentist, 9, 23, 10.1111/j.1754-4505.1989.tb01016.x · doi:10.1111/j.1754-4505.1989.tb01016.x
  185. Pence, 1974, Prophylactic use of epsilon aminocaproic acid for oral surgery in a patient with hereditary angioneurotic edema, J Allergy Clin Immunol, 53, 298, 10.1016/0091-6749(74)90109-2 · doi:10.1016/0091-6749(74)90109-2
  186. Crosher, 1987, Intravenous tranexamic acid in the management of hereditary angio-oedema, Br J Oral Maxillofac Surg, 25, 500, 10.1016/0266-4356(87)90143-4 · doi:10.1016/0266-4356(87)90143-4
  187. Hardie, 1990, Potentially fatal hereditary angioedema: a review and case report, J Can Dent Assoc, 56, 1096
  188. Farkas, 1999, The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures, J Oral Maxillofac Surg, 57, 404, 10.1016/S0278-2391(99)90280-X · doi:10.1016/s0278-2391(99)90280-x
  189. Peled, 1997, Preoperative prophylaxis for C1 esterase-inhibitor deficiency in patients undergoing oral surgery: a report of three cases, Quintessence Int, 28, 169
  190. Leimgruber, 1993, Hereditary angioedema: uncomplicated maxillofacial surgery using short-term C1 inhibitor replacement therapy, Int Arch Allergy Immunol, 101, 107, 10.1159/000236506 · doi:10.1159/000236506
  191. Langton, 1994, C1-esterase inhibitor concentrate prevents upper airway obstruction in hereditary angio-oedema, Med J Aust, 160, 383, 10.5694/j.1326-5377.1994.tb138252.x · doi:10.5694/j.1326-5377.1994.tb138252.x
  192. Bain, 1993, Acquired angioedema as the presenting feature of lymphoproliferative disorders of mature B-lymphocytes, Cancer, 72, 3318, 10.1002/1097-0142(19931201)72:11<3318::AID-CNCR2820721130>3.0.CO;2-N · doi:10.1002/1097-0142(19931201)72:11<3318::aid-cncr2820721130>3.0.co;2-n
  193. Bouillet, 2000, [Acquired angioneurotic edema: clinical and biological characteristics in 9 patients], Presse Med, 29, 640
  194. Phanish, 2002, Spontaneous regression of acquired C1 esterase inhibitor deficiency associated with splenic marginal zone lymphoma presenting with recurrent angio-oedema, J Clin Pathol, 55, 789, 10.1136/jcp.55.10.789 · doi:10.1136/jcp.55.10.789
  195. Donaldson, 1992, Angioneurotic edema with acquired C1-inhibitor deficiency and autoantibody to C1-inhibitor: response to plasmapheresis and cytotoxic therapy, J Lab Clin Med, 119, 397
  196. Gröner, 2002, Purity, activity, and virus safety of a pasteurized antithrombin concentrate, Semin Thromb Hemost, 28, 79, 10.1055/s-2002-30200 · doi:10.1055/s-2002-30200
  197. Heimburger, 1981, A factor VIII concentrate, highly purified and heated in solution, Haemostasis, 10, 204
  198. Hilfenhaus, 1990, Virus-safe plasma proteins: elimination of viruses of risk by the manufacturing procedure, Transf Sci, 11, 35S, 10.1016/0955-3886(90)90080-3 · doi:10.1016/0955-3886(90)90080-3
  199. Hilfenhaus, 1994, Inactivation of hepatitis A virus by pasteurization and elimination of picornaviruses during manufacture of factor VIII concentrate, Vox Sang, 67, 62, 10.1111/j.1423-0410.1994.tb00980.x · doi:10.1111/j.1423-0410.1994.tb00980.x
  200. Chandra, 2002, Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products, Thromb Res, 105, 391, 10.1016/S0049-3848(02)00044-0 · doi:10.1016/s0049-3848(02)00044-0

200 of 241 shown

Cited by

See all 646

Metadata

Authors
Agostoni, A., Aygören-Pürsün, E., Binkley, K. E., Blanch, A., Bork, K., Bouillet, L., Bucher, C., Castaldo, A. J., Cicardi, M., Davis, A. E., De Carolis, C., Drouet, C., Duponchel, C., Farkas, H., Fáy, K., Fekete, B., Fischer, B., Fontana, L., Füst, G., Giacomelli, R., Gröner, A., Erik Hack, C., Harmat, G., Jakenfelds, J., Juers, M., Kalmár, L., Kaposi, P. N., Karádi, I., Kitzinger, A., Kollár, T., Kreuz, W., Lakatos, P., Longhurst, H. J., Lopez-Trascasa, M., Martinez-Saguer, I., Monnier, N., Nagy, I., Németh, É., Nielsen, E. W., Nuijens, J. H., O'Grady, C., Pappalardo, E., Penna, V., Perricone, C., Perricone, R., Rauch, U., Roche, O., Rusicke, E., Späth, P. J., Szendei, G., Takács, E., Tordai, A., Truedsson, L., Varga, L., Visy, B., Williams, K., Zanichelli, A., & Zingale, L.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2004-09
Volume
114
Issue
3
Pages
S51-S131
ISSN
0091-6749 (ISSN-L)
OpenAlex
W2081368903
Cited by
646
References
216
FWCI
11.36
Type
journal article
Language
en
Open access
bronze
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.